Home > Keywords >
Catalog | name | Description | price |
---|---|---|---|
R-R-4727 | Heptakis(2,3,6-tri-O-benzoyl)-b-cyclodextrin CAS No.23666-43-5 | Heptakis(2,3,6-tri-O-benzoyl)-β-cyclodextrin/CAS No.23666-43-5 is a biochemical reagent that can be used as a biological material or organic compound for life science related research. | price> |
R-C-3058 | Paeoniflorin (NSC 178886) CAS:23180-57-6 | Paeoniflorin (NSC 178886) is a herbal constituent extracted from the root of Paeonia albiflora Pall. Paeoniflorin reduces COX-2 expression. Paeoniflorin alleviates liver fibrosis by inhibiting HIF-1α through mTOR-dependent pathway. | price> |
R-R-4728 | Mono-2-O-(p-toluenesulfonyl)-a-cyclodextrin CAS No.93184-10-2 | Mono-2-O-(p-toluenesulfonyl)-α-cyclodextrin/Mono-2-o-(p-toluenesulfonyl)-alpha-cyclodextrin/CAS No.93184-10-2 is a biochemical reagent that can be used as a biological material or organic compound for life science related research. | price> |
R-C-3059 | HUN86320 CAS:882286-32-0 | TSPC is an inhibitor for GA perception by in vitro and in planta evaluations. | price> |
R-R-4729 | Mono-2-O-(p-toluenesulfonyl)-y-cyclodextrin CAS No.97227-32-2 | Mono-2-O-(p-toluenesulfonyl)-γ-cyclodextrin/Mono-2-O-(p-toluenesulfonyl)-gamma-cyclodextrin/CAS No.97227-32-2 is a biochemical reagent that can be used as a biological material or organic compound for life science related research. | price> |
R-C-3060 | BRD3731 cas:2056262-07-6 | BRD3731 is a selective GSK3β inhibitor, with IC50s of 15 nM and 215 nM for GSK3β and GSK3α, respectively. BRD3731 inhibits the phosphorylation of CRMP2 in SH-SY5Y cells. BRD3731 decreases β-catenin S33/37/T41 phosphorylation and induces β-catenin S675 phosphorylation in HL-60 cells. BRD3731 impairs colony formation in TF-1 and increases colony forming ability in the MV4-11 cell line. | price> |
R-R-4730 | Mono-6-O-(p-toluenesulfonyl)-a-cyclodextrin CAS No.97227-32-2 | Mono-6-O-(p-toluenesulfonyl)-α-cyclodextrin/Mono-6-O-(p-toluenesulfonyl)-alpha-cyclodextrin/CAS No.97227-32-2 is a biochemical reagent that can be used as a biological material or organic compound for life science related research. | price> |
R-C-3061 | BRD3308 CAS:1550053-02-5 | BRD3308 is a highly selective HDAC3 inhibitor with an IC50 of 54 nM. | price> |
R-R-4731 | Mono-6-O-mesitylenesulfonyl-y-cyclodextrin CAS No.174010-62-9 | Mono-6-O-mesitylenesulfonyl-γ-cyclodextrin/CAS No.174010-62-9 is a biochemical reagent that can be used as a biological material or organic compound for life science related research. | price> |
R-C-3062 | BRD0705 CAS:2056261-41-5 | BRD0705 is a potent, paralog selective and orally active GSK3α inhibitor. | price> |
R-R-4732 | Mono-6-O-(p-toluenesulfonyl)-y-cyclodextrin CAS No.97227-33-3 | Mono-6-O-(p-toluenesulfonyl)-γ-cyclodextrin is a biochemical reagent that can be used as a biological material or organic compound for life science related research. | price> |
R-C-3063 | SB415286 CAS: 264218-23-7 | SB415286 is a potent GSK3α inhibitor with IC50/Ki of 78 nM/31 nM with equally effective inhibition of GSK-3β. SB415286 causes MM cell growth arrest and apoptosis. | price> |
R-R-4733 | Hexakis (2,3,6-tri-O-methyl)-a-cyclodextrin CAS No.68715-56-0 | Hexakis (2,3,6-tri-O-methyl)-α-cyclodextrin/Hexakis (2,3,6-tri-O-methyl)-alpha-cyclodextrin/CAS No.68715-56-0 is a biochemical reagent that can be used as a biological material or organic compound for life science related research. | price> |
R-C-3064 | LY2090314 CAS:603288-22-8 | LY2090314 is a potent GSK-3 inhibitor for GSK-3α/β with IC50 of 1.5 nM/0.9 nM; may improve the efficacy of platinum-based chemotherapy regimens. LY2090314 is highly selective towards GSK3 as demonstrated by its fold selectivity relative to a large panel of kinases. | price> |
R-R-4734 | Heptakis(2,3,6-tri-O-ethyl)-b-cyclodextrin CAS No.111689-01-1 | Heptakis(2,3,6-tri-O-ethyl)-β-cyclodextrin/CAS No.111689-01-1 is a biochemical reagent that can be used as a biological material or organic compound for life science related research. | price> |
R-C-3065 | BX517 CAS:850717-64-5 | BX517 is a potent and selective inhibitor of PDK1 that binds to the ATP binding pocket of the protein (IC50 = 6 nM). | price> |
R-R-4735 | Heptakis-(2,6-di-O-ethyl)-b-cyclodextrin CAS No.111689-03-3 | Heptakis-(2,6-di-O-ethyl)-β-cyclodextrin/DE-beta-Cyd/CAS No.111689-03-3 is a biochemical reagent that can be used as a biological material or organic compound for life science related research. | price> |
R-C-3066 | GSK2334470 CAS:1227911-45-6 | GSK2334470 is a novel PDK1 inhibitor with IC50 of ~10 nM in a cell-free assay, with no activity at other close related AGC-kinases.Only for scientific research, not for human body. | price> |
R-R-4736 | Maltooctaose CAS No.66567-45-1 | Maltooctaose/CAS No.66567-45-1, a specific-length maltooligosaccharide, can be produced by PFTA (Pyrococcus furiosus). | price> |
R-C-3067 | SL-0101-1 cas:77307-50-7 | SL 0101-1 is a selective p90 ribosomal S6 kinase (RSK) inhibitor for RSK2 with an IC50 of 89 nM. The IC50 of kaempferol, the flavonoid constituent of SL 0101-1, is 15 μM for RSK. The rhamnose moiety of SL 0101-1 increases the affinity for RSK by >150-fold. Only for scientific research, not for human body. | price> |